{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T01:31:45Z","timestamp":1726191105375},"reference-count":66,"publisher":"Informa UK Limited","issue":"7","license":[{"start":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T00:00:00Z","timestamp":1656806400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Merck & Co., Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2022,7,3]]},"DOI":"10.1080\/17474086.2022.2080050","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T03:52:35Z","timestamp":1657165955000},"page":"607-617","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["A systematic literature review of the epidemiology, quality of life, and economic burden, including disease pathways and treatment patterns of relapsed\/refractory classical Hodgkin lymphoma"],"prefix":"10.1080","volume":"15","author":[{"given":"Monika","family":"Raut","sequence":"first","affiliation":[{"name":"CORE Oncology, Merck & Co Inc, Kenilworth, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautamjeet","family":"Singh","sequence":"additional","affiliation":[{"name":"Regulatory and Access, Parexel International, Mohali, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Immaculata","family":"Hiscock","sequence":"additional","affiliation":[{"name":"CORE Oncology, Merck & Co Inc, Kenilworth, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheetal","family":"Sharma","sequence":"additional","affiliation":[{"name":"Regulatory and Access, Parexel International, Mohali, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nameeta","family":"Pilkhwal","sequence":"additional","affiliation":[{"name":"Regulatory and Access, Parexel International, Mohali, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0189-6"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy080"},{"key":"cit0003","unstructured":"GLOBOCAN. GLOBOCAN 2018: estimated cancer incidence, mortality, and prevalence worldwide in 2018. Available from: https:\/\/gco.iarc.fr\/today\/online-analysis-table?v=2018&mode=population&mode_population=countries&population=900&populations=900&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&group_cancer=1&include_nmsc=1&include_nmsc_other=1. Cited 2021 Apr 21."},{"key":"cit0004","unstructured":"National cancer institute: Surveillance epidemiology, and end results program (SEER). 2021. Cancer stat facts: Hodgkin lymphoma. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/hodg.html. Cited 2021 Apr 21."},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-019-00792-7"},{"key":"cit0006","unstructured":"National Institute for Health and Care Excellence. March 2017. Health technology appraisal. Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma. Available from: https:\/\/www.nice.org.uk\/guidance\/ta540\/documents\/final-scope. Cited 2021 Apr 21."},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60165-9"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-07-861641"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000324"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.0793"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-016-0515-6"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V120.21.4782.4782"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1493732"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.022"},{"issue":"30","key":"cit0016","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1200\/JCO.2017.72.6869","volume":"35","author":"Martinez C","year":"2017","journal-title":"J Clin Oncol"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.4636.4636"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31114"},{"issue":"22","key":"cit0019","first-page":"128","author":"Dulery R","year":"2016","journal-title":"Blood"},{"issue":"31","key":"cit0020","first-page":"535","volume":"115","author":"Br\u00f6ckelmann PJ","year":"2018","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"cit0021","first-page":"83","volume":"102","author":"Byrne K","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"cit0022","first-page":"4705","volume":"130","author":"Chen C","year":"2017","journal-title":"Blood"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1421762"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14316"},{"issue":"5","key":"cit0025","first-page":"A124","volume":"20","author":"Szabo SM","year":"2017","journal-title":"Value Health"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180261"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(03)00545-8"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.5507"},{"key":"cit0029","first-page":"S108","volume":"45","author":"Magagnoli M","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12038"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30167-X"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1602262"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1002\/hon.174_2631"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1540781"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30192-3"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-121997"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S178649"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1030639"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1002\/hon.175_2631"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.244"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25240"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.767902"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28698"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.056010"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2018.1534738"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30818"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2016.1219358"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.3747\/co.24.3369"},{"issue":"1","key":"cit0049","first-page":"2166","volume":"130","author":"Tan M","year":"2017","journal-title":"Blood"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.08.203"},{"issue":"5","key":"cit0051","first-page":"A359","volume":"20","author":"Patidar M","year":"2017","journal-title":"Value Health"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.09.2214"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.09.2217"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.08.223"},{"key":"cit0055","unstructured":"NCCN National Comprehensive Cancer Network\u00ae. Clinical practice guidelines in oncology (NCCN guidelines). Hodgkin Lymphoma. 2020;Version 1.2020."},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.02.022"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-015-1429-1"},{"key":"cit0058","volume-title":"Lymphoid malignancies. part 1: Hodgkin lymphoma","author":"Eccersley L","edition":"2020"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000736"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1508665"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-129632"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-113682"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu387"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07727.x"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2013.02.002"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn384"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2022.2080050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T10:16:53Z","timestamp":1659781013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2022.2080050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,3]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,3]]}},"alternative-id":["10.1080\/17474086.2022.2080050"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2022.2080050","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-12-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}